Is a single dose of ChAdOx1 nCoV‐19 vaccine (AZD1222) enough for people with prior SARS‐CoV‐2 infection or baseline seropositive status?
Auteurs principaux: | , , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Elsevier
2022-10-01
|
Collection: | International Journal of Infectious Diseases |
Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S1201971222003848 |